Assessing the Safety and Tolerability of CSL730 in Healthy Caucasian and Japanese Adults
Clinical trial NCT03375606 · TERMINATED
Trial details
- NCT number
- NCT03375606
- Sponsor
- CSL Behring
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-10
- Primary completion
- 2020-06-22
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.